In 2009 Sopharma Trading Jsc. has realized sales in the amount of BGN 361 029 000, which marks a growth of 8.1% as compared to the same period of 2008. This is a net financial result of BGN 5 334 000. Thus, Sopharma Trading Jsc. ranks among the leaders on the Bulgarian pharmaceutical market with a market share of 20.7% and for a third successive year remains the most rapidly developing distributor within the sector.
The market share of Sopharma Trading JSC., according to IMS Health for December 2009 equals 20.7 % in value; 20.9% for the pharmacy market and 20.1% for the hospital market.
| Indicators | 2008 | 2009 |
| Operating income (BGN000) | 333 863 | 361 029 |
| Net operating profit/loss(BGN000) | 5 281 | 5 334 |
| Net profit/loss per share (BGN) | 0.176 | 0.178 |
| Indicators | 2008 | 2009 |
| Total assets (BGN000) | 151 773 | 182 402 |
| Equity (BGN000) | 48 995 | 51 329 |
| Number of shares (BGN000) | 30 000 | 30 000 |